Yang 2014.

Methods	Design: parallel RCT Randomisation method: not reported Blinding: no Power calculation: no Dropouts/withdrawals: no
Participants	Cancer patients with expected survival time of more than 3 months; Karnofsky ≥ 60 Number (treatment/control): 62 (32/30) Mean age (range): not reported Gender (M/F): 35/27 Country: Jiangsu province, China Setting: hospital
Interventions	Moxa stick + conventional medicine vs conventional medicine Treatment group Moxa stick Moxa stick on the acupoints RN8 (shenque) and bilateral ST36 (zusanli) for 15 minutes per acupoint, additional acupoint RN6 (qihai) for those with syndrome of qi deficiency or acupoint RN12 (zhongwan) for those with nausea and vomiting, once per day, 5 times per week Treatment duration: 30 days (beginning at the same day of chemotherapy) Conventional treatment Dexamethasone and ondansetron Chemotherapy Control group Conventional treatment Dexamethasone and ondansetron Chemotherapy
Outcomes	WBC count, Hb, platelet, vomiting (WHO grade 3 to 4), Karnofsky score at the end of treatment
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not described
Allocation concealment (selection bias)	Unclear risk	No relevant description
Incomplete outcome data (attrition bias) All outcomes	Low risk	None lost to follow‐up
Selective reporting (reporting bias)	Unclear risk	Limited outcome measures were reported.
Other bias	Low risk	Baseline characteristic data were comparable.
Blinding of participants and personnel (performance bias) All outcomes	High risk	No blinding
Blinding of outcome assessment (detection bias) Subjective outcomes	High risk	No blinding
Blinding of outcome assessment (detection bias) Objective outcomes	Low risk	No blinding; however, machine‐measured objective outcomes were not influenced substantially